Momoko Yoshimoto
Overview
Explore the profile of Momoko Yoshimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
2654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Protocol to induce cell labeling in vivo and to trace labeled hematopoietic cells using mouse models
Syed A, Kobayashi M, Yoshimoto M
STAR Protoc
. 2024 Oct;
5(4):103408.
PMID: 39436772
A combination of hematopoietic stem cell (HSC)- and endothelial cell (EC)-lineage-tracing mouse models enables us to determine blood cell origins. We present a protocol to induce cell labeling in vivo...
2.
Rezvani M, Lewis K, Quach S, Iwasawa K, Weihs J, Reza H, et al.
bioRxiv
. 2024 Oct;
PMID: 39416072
The fetal liver is a hematopoietic organ, hosting a diverse and evolving progenitor population. While human liver organoids derived from pluripotent stem cells (PSCs) mimic aspects of embryonic and fetal...
3.
Lin Y, Gil C, Banno K, Yokoyama M, Wingo M, Go E, et al.
Circulation
. 2024 Apr;
150(6):451-465.
PMID: 38682338
Background: Most organs are maintained lifelong by resident stem/progenitor cells. During development and regeneration, lineage-specific stem/progenitor cells can contribute to the growth or maintenance of different organs, whereas fully differentiated...
4.
Jain A, Casanova D, Valdivia Padilla A, Paniagua Bojorges A, Kotla S, Ko K, et al.
Front Cardiovasc Med
. 2023 Oct;
10:1212174.
PMID: 37781317
Cardiovascular disease (CVD) is a leading cause of morbidity and mortality, especially among the aging population. The "response-to-injury" model proposed by Dr. Russell Ross in 1999 emphasizes inflammation as a...
5.
Abe J, Imanishi M, Li S, Zhang A, Ko K, Samanthapudi V, et al.
Circ Res
. 2023 Jun;
133(1):25-44.
PMID: 37264926
Background: ERK5 (extracellular signal-regulated kinase 5) is a dual kinase transcription factor containing an N-terminal kinase domain and a C-terminal transcriptional activation domain. Many ERK5 kinase inhibitors have been developed...
6.
Kobayashi M, Yoshimoto M
Immunol Rev
. 2023 Mar;
315(1):11-30.
PMID: 36929134
It has been over three decades since Drs. Herzenberg and Herzenberg proposed the layered immune system hypothesis, suggesting that different types of stem cells with distinct hematopoietic potential produce specific...
7.
Kobayashi M, Wei H, Yamanashi T, Azevedo Portilho N, Cornelius S, Valiente N, et al.
Cell Rep
. 2023 Mar;
42(3):112239.
PMID: 36906851
It is widely believed that hematopoiesis after birth is established by hematopoietic stem cells (HSCs) in the bone marrow and that HSC-independent hematopoiesis is limited only to primitive erythro-myeloid cells...
8.
Lin Y, Banno K, Gil C, Myslinski J, Hato T, Shelley W, et al.
JCI Insight
. 2023 Jan;
8(5).
PMID: 36692963
Most circulating endothelial cells are apoptotic, but rare circulating endothelial colony-forming cells (C-ECFCs), also known as blood outgrowth endothelial cells, with proliferative and vasculogenic activity can be cultured; however, the...
9.
Imanishi M, Cheng H, Kotla S, Deswal A, Le N, Chini E, et al.
Front Cardiovasc Med
. 2022 Nov;
9:988713.
PMID: 36426217
Radiation therapy (RT) to the chest increases the patients' risk of cardiovascular disease (CVD). A complete understanding of the mechanisms by which RT induces CVD could lead to specific preventive,...
10.
Yoshimoto M, Kosters A, Cornelius S, Valiente N, Cheng H, Latorre A, et al.
Front Immunol
. 2022 Jul;
13:896396.
PMID: 35898504
Recent advances in developmental immunology have revealed a hematopoietic stem cell (HSC)-independent origin for various innate immune lineages, including mast cells (MCs). It is now established that adult bone marrow...